|
|
| Line 26: |
Line 26: |
| <span style="display:none">Fallopian tubes</span> | | <span style="display:none">Fallopian tubes</span> |
| <span style="display:none">Endometrium</span> | | <span style="display:none">Endometrium</span> |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | | <span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> |
| <span style="display:none">isPatientAssociation</span> | | <span style="display:none">isPatientAssociation</span> |
| | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C50: Breast cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forpatients francecountry
Go back to France page
Primary purpose: To support families affected by Lynch syndrome by promoting research, disseminating research findings, advocating for prevention measures, providing support and information to families, and raising awareness among the public and healthcare professionals about this hereditary predisposition.
Cancer areas of interest: C15-C26: Digestive system cancers, and C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to learn more.
Esophagus
Stomach
Small intestine
Large intestine
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Colon
Vulva
Vagina
Cervix
Uterus
Ovary
Fallopian tubes
Endometrium
hasCancerType::C51-C58: Female genitalia cancer
isPatientAssociation
hasCancerType::C15-C26: Digestive system cancers
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
